Ryan Kraus, MD
Radiation Oncology · Kennewick, WANPI 1528509767
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,438 of the $10,945 with a category attached, or 86.2%. Servier Pharmaceuticals LLC accounts for 96.8% of it on its own, with 3 other manufacturers making up the rest. 2024 is the largest year on record at $10,593, more than ten times the $29 reported in 2021. Among radiation oncology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $994.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$11K
- Reflexion Medical, Inc.$213
- Novocure Inc.$110
- Boston Scientific$29
What the payments were for
- Consulting fees$9,43886%
- Travel & lodging$5685%
- Food & beverage$9399%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 8 | $10,593 |
| Reflexion Medical, Inc. | 1 | $213 |
| Novocure Inc. | 1 | $110 |
| Boston Scientific | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,945 in reported general payments places this provider in the 90th percentile of 168 radiation oncology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 59 | $746 |
| Lidocaine Hcl ViscousLidocaine Hcl | 36 | $308 |
| Mometasone Furoate | 13 | $223 |
| Fluconazole | 13 | $142 |
| Dexamethasone | 20 | $101 |
| Lorazepam | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Kennewick
- Juno ChoeKennewick$11K
- Sherry ZhaoKennewick$689
- Christopher LeeSpokane Valley$138K
- Vivek MehtaSeattle$120K
- Christopher LoiselleSeattle$63K
- Ramesh RenganSeattle$57K
- Jing ZengSeattle$37K
- Omar MianSeattle$22K
- Susan GuoTacoma$18K
- Richard HsiSeattle$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.